Balance of inflammatory cytokines related to severity and mortality of murine sepsis

Infection and Immunity

Volumn 64, Issue 11, 1996, Pages 4733-4738

  Walley, Keith R ^a   Lukacs, Nicholas W ^b   Standiford, Theodore J ^c   Strieter, Robert M ^c   Kunkel, Steven L ^b,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; LIVER; LUNG; MORTALITY; MOUSE; NONHUMAN; PERITONEAL FLUID; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK;

EID: 0029999510     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.11.4733-4738.1996     Document Type: Article

References (32)

1. Abraham, E., and T. A. Raffin. 1994. Sepsis therapy trials: continued disappointment or reason for hope? JAMA 271:1876-1878.
2. Abraham, E., R. Wunderink, H. Silverman, T. M. Perl, S. Nasraway, H. Levy, R. Bone, R. P. Wenzel, R. Balk, R. Allred, J. E. Pennington, and J. C. Wherry for the TNF-α MAb Sepsis Study Group. 1995. JAMA 273:934-941.
3. Bagby, G. J., K. J. Plessala, L. A. Wilson, J. J. Thompson, and S. Nelson. 1991. Divergent efficacy of antibody to tumor necrosis factor-α in intravascular and peritonitis models of sepsis. J. Infect. Dis. 163:83-88.
4. Baker, C. C., I. H. Chaudry, H. O. Gaines, and A. E. Baue. 1983. Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 94:331-335.
5. Brigham, K. L., and B. Meyrick. 1986. Endotoxin and lung injury. Am. Rev. Respir. Dis. 133:913-927.
6. Calandra, T., J.-D. Baumgartner, G. E. Grau, M.-M. Wu, P.-H. Lambert, J. Schellekens, J. Verhoef, M. P. Glauser, and the Swiss-Dutch J5 Immunoglobulin Study Group. 1990. Prognostic values of tumor necrosis factor: cachectin, interleukin-1, interferon-α, and interferon-γ in the serum of patients with septic shock. J. Infect. Dis. 161:982-987.
7. Cannon, J. G., R. G. Tompkins, J. A. Gelfand, H. R. Michie, G. G. Stanford, J. W. M. van der Meer, S. Endres, G. Lonnemann, J. Corsetti, B. Chernow, D. W. Wilmore, S. M. Wolff, J. F. Burke, and C. A. Dinarello. 1990. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J. Infect. Dis. 161:79-84.
8. Casey, L. C., R. A. Balk, and R. C. Bone. 1993. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann. Intern. Med. 119:771-778.
9. Chensue, S. W., D. G. Remick, C. Shmyr-Forsch, T. F. Beals, and S. L. Kunkel. 1988. Immunochemical demonstration of cytoplasmic and membrane associated tumor necrosis factor in murine macrophage. Am. J. Path. 133:564-572.
10. Damas, P., D. Ledoux, M. Nys, Y. Vrindts, D. De Groote, P. Franchimont, and M. Lamy. 1992. Cytokine serum level during severe sepsis in human: IL-6 as a marker of severity. Ann. Surg. 215:356-362.
11. de Waal Malefyl, R., J. Abrams, B. Bennet, C. G. Figdor, and J. E. de Vries. 1991. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulalory role of IL-10 produced by monocytes. J. Exp. Med. 174: 1209-1220.
12. Echtenacher, B., W. Falk, D. N. Mannel, and P. H. Krammer. 1990. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J. Immunol. 145:3762-3766.
13. Eskandari, M. K., G. Bologos, C. Miller, D. T. Nguyen, L. E. DeForge, and D. G. Remick, 1992. Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J. Immunol. 148:2724-2730.
14. Eskandari, M. K., D. T. Nguyen, S. L. Kunkel, and D. G. Remick. 1990. WEHI 164 subclone 13 assay for TNF: sensitivity, specificity, and reliability. Immunol. Invest. 19:69-79.
15. Finkel, M. S., C. V. Oddis, T. D. Jacob, S. C. Watkins, B. G. Hattler, and R. L. Simmons. 1992. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257:387-389.
16. Fiorentino, D. F., A. Zlotnik, T. R. Mosmann, M. Howard, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:3815-3822.
17. Folrquin, S., Z. Amraoui, D. Abramowicz, and M. Goldman. 1994. Systemic release and protective role of IL-10 in staphlococcal enterotoxin B-induced shock in mice. J. Immunol. 153:2618-2623.
18. Gerard, C., C. Bruyns, A. Marchant, D. Abramowicz, P. Vandenabeele, A. Delvaux, W. Fiers, M. Goldman, and T. Velu. 1993. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177:547-550.
19. Girardin, E., G. E. Grau, J.-M. Dayer, P. Roux-Lombard, the J5 Study Group, and P.-H. Lambert. 1988. Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N. Engl. J. Med. 319:397-400.
20. Herbertson, M. J., H. A. Werner, C. M. Goddard, J. A. Russell, A. Wheeler, R. Coxon, and K. R. Walley, 1995. Anti-tumor necrosis factor-α prevents decreased ventricular contractility in endotoxemic pigs. Am J. Respir. Crit. Care Med. 152:480-488.
21. Holland, B. S., and M. DiPonzi Copenhaver. 1987. An improved sequentially rejective Bonferroni test procedure. Biometrics 43:417-423.
22. Marchant, A., C. Bruyns, P. Vandenabeele, M. Ducarme, C. Gerard, A. Delvaux, D. DeGroote, D. Abramowicz, T. Velu, and M. Goldman. 1994. Interleukin-10 controls interferon-7 and tumor necrosis factor production during experimental endotoxemia. Eur. J. Immunol. 24:1167-1171.
23. Marchant, A., J. Deviere, B. Byl, D. De Groote, J.-L. Vincent, and M. Goldman. 1994. Interleukin-10 production during septicaemia. Lancet 343: 707-708.
24. Moore, K. W., A. O'Garra, R. de Waal Malefyt, P. Vieira, and T. R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11:165-190.
25. Morrissey, P. J., T. Sato, and S. Braddy. 1992. The response of the IL-6-dependent cell line, B9, to IL-6 is not augmented by recombinant derived purified IL-2. J. Immunol. Methods 147:141-143.
26. Pinsky, M. R. 1989. Multiple systems organ failure: malignant intravascular inflammation. Crit. Care Clinics 5:195-198.
27. Standiford, T. J., R. M. Strieter, N. W. Lukacs, and S. L. Kunkel. 1995. Neutralization of IL-10 increases lethality in endotoxemia: cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J. Immunol. 155:2222-2229.
28. Tracey, K. J., B. Beutler, S. F. Lowry, J. Merryweather, S. Wolpe, I. W. Milsark, R. J. Hariri, T. J. Fahey III, A. Zentella, J. D. Albert, G. T. Shires, and A. Cerami. 1986. Shock and tissue injury induced by recombinant human cachectin. Science 234:470-474.
29. Tracey, K. J., Y. Fong, D. G. Hesse, K. R. Manogue, A. T. Lee, G. C. Kuo, S. F. Lowry, and A. Cerami. 1987. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteremia. Nature (London) 330:662-664.
30. van der Poll, T., J. Jansen, M. Levi, H. ten Cale, J. Wouter ten Cate, and S. J. H. van Deventer. 1994. Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees. J. Exp. Med. 180:1985-1988.
31. van der Poll, T., A. Marchant, W. A. Buurman, L. Berman, C. V. Keogh, D. D. Lazarus, L. Nguyen, M. Goldman, L. L. Moldawer, and S. F. Lowry. 1995. Endogenous IL-10 protects mice from death during septic peritonitis. J. Immunol. 155:5397-5401.
32. Waage, A., A. Halstensen, and T. Espevik. 1987. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet i:355-357.